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Abstract
Objective: Young adulthood is an important period for both bone and mental health. This study investigated the
association between depressive symptoms and bone density in apparently healthy Korean men and women aged 29232
years.
Methods: This study is a cross-sectional analysis of data from 123 men and 133 women who completed follow-up
examinations of the Kangwha study in 201022011. Bone stiffness index (SI) was measured at the os calcis using a
quantitative ultrasound device. Depressive symptoms were evaluated using the Korean version of the Beck Depression
Inventory (K-BDI) and classified as normal (K-BDI ,10), mild (K-BDI 10–15), and moderate to severe (K-BDI $16).
Results: Moderate to severe depressive symptoms were prevalent among 11.4% of men and 19.6% of women. Higher K-BDI
scores were significantly correlated to SI in men, before (r= –0.286, p= 0.001) and after (r= –0.228, p= 0.013) adjustment for
covariates. Men with depressive symptoms tended to have a lower SI; multivariate-adjusted mean SI in men with normal,
mild, and moderate to severe depressive symptoms was 104.163.1, 100.965.9, and 94.167.8, respectively (p for
trend= 0.021). In contrast, no significant correlations were identified in women.
Conclusions: Depressive symptoms were significantly associated with lower SI in men, but not in women. Further studies
are necessary to evaluate the impact of depression on developing osteoporosis or osteoporotic fractures later in life.
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Introduction
Osteoporosis is characterized by low bone mass and micro-
architectural deterioration of bone tissue, with a consequent
increase in bone fragility and susceptibility to fracture [1].
Osteoporosis is usually asymptomatic, but osteoporotic fracture
can cause considerable health care burden due to hospitalization,
limited mobility, and significant mortality. Osteoporosis is a
prevalent disease, afflicting over 200 million patients worldwide,
and prevalence increases as the population ages [2]. Consequently,
health care costs are estimated to be doubled by 2050 [2]. Bone
mass increases to peak until 20 to 30 years of age and generally
decreases with age [3]. Achieving high peak bone mass in young
adulthood is important because it predicts a relatively higher bone
mass and a lower osteoporotic fracture incidence in later life [3].
Young adulthood is also an important period for mental health;
between 20 and 30 years of age is the most common time of
depression onset [4]. In the World Mental Health Survey, the
mean age for the onset of depression was 28.9 years in 10
developed countries and 27.2 years old in developing countries [4].
Depression is also common mental disorder; at least 350 million
people suffered from depression worldwide [5]. Furthermore,
depression is the leading cause of disability because it can become
chronic or recurrent, substantially impairing an individuals’
quality of life [5].
Interestingly, since a case-control study suggested an inverse
association between major depressive disorder (MDD) and lumbar
bone mineral density (BMD) [6], the link between depression and
BMD has been continuously studied. Recently, systematic reviews
and meta-analyses of epidemiologic studies demonstrated that
MDD was associated with lower BMD [7–9]. Specifically, in a
systematic review, 76% (25 out of 33) of the qualified articles
reported an inverse association between depression or depressive
symptoms and BMD at the AP spine, femoral neck, and total
femur [9]. In relation to areal BMD at the forearm, a large scale
community study with 1,194 men and 7,842 women demonstrated
a negative association between depressive symptoms and BMD in
men and heavier women in a cross-sectional analysis [10].
However, previous studies were performed mainly in middle-aged
or older white populations. For young adults, limited information
is available and the results are inconsistent. In a nationwide study
with various ethnic groups in the U.S., MDD or dysthymia was
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associated with lower BMD in men, but not in women [11]. In
addition, several studies in premenopausal women showed either
inverse associations between depression and BMD or no
significant associations [7–9]. The inconsistent results may be
due to small sample size, differences in study design, use of
different assessment tools for depression and BMD, or evaluating
different ethnic groups. Still, little evidence is available in young
Asian men and women. Therefore, the current study aimed to
investigate the association between depressive symptoms and bone
density in apparently healthy Korean men and women aged 29 to
32 years.
Materials and Methods
Study Participants
The Kangwha Study is a community-based prospective cohort
study which began in 1986 with 6-year-old school children in
Kangwha County located on the West coast of South Korea.
Details of this study were previously described [12,13]. BMD
measurements have been added in 2010; therefore, the present
study is a cross-sectional analysis of data from follow-up
examinations in 2010 and 2011. Among 123 men and 141
women aged 29 to 32 years, eight participants were excluded from
the present analyses due to at least one of the following reasons:
absence of bone density measurement (n = 1), previously diag-
nosed depression (n= 3), missing blood tests (n = 1), or unknown
age at menarche (n= 6). The participants diagnosed with
depression were excluded to avoid effects of antidepressants or
other lifestyle changes due to the known depression. Additionally,
no participant reported to have been diagnosed cancer, stroke,
ischemic heart disease, or osteoporosis. Finally, 256 participants
(123 men and 133 women) were eligible for this study. All
participants in this survey provided written informed consent. This
study was approved by the Institutional Review Board of Yonsei
University Health System (4–2009–0624) and monitored by the
Human Research Protection Center of Severance Hospital,
Yonsei University Health System.
Measurements
Trained research staffs explained the study questionnaires to
participants and asked questions pertaining medical history, health
behavior, and other health-related information. Anthropometrics
and blood pressure were measured according to the pre-developed
protocol. Body mass index (BMI) was calculated as weight in
kilograms divided by height in meters squared. Smoking status was
categorized as either current smoker versus non-smoker (past or
never). At-risk drinking was defined as consuming an average of
more than 2 drinks/day for men and 1 drink/day for women.
Blood samples were collected after an 8-hour fasting period and
handled according to standard procedures. Bone stiffness index
(SI) at the os calcis was measured using a quantitative ultrasound
(QUS) device, the Achilles Express ultrasonometer (GE Medical
Systems LUNAR, WI, USA). SI was calculated using the values of
the velocity and the frequency-dependent attenuation of the sound
waves; SI = (0.676broadband ultrasound attenuation in dB/
MHz)+(0.286speed of sound in m/sec) –420. Although the
QUS method is an alternative tool to evaluate bone density, the
GE Lunar Achilles that we used in this study has been proven in
clinical studies and the SI value is considered to be clinically useful
[14]. Quality assurance was confirmed using a phantom every
week according to the protocol. Precision for the QUS phantom
was comparable to that of dual energy X-ray absorptiometry
(DXA) with a coefficient variation of SI of around 2% [15].The
Korean version of the Beck Depression Inventory (K-BDI) was
used to assess depressive symptoms. The BDI is a widely used
screening tool for depression that consists of 21 items assessing
symptoms and attitudes more frequently observed in depressed
patients [16,17]. Each item can be rated from 0 to 3 in terms of
intensity, and higher scores reflect more severely depressed mood.
The K-BDI is a translated and validated version of the BDI for use
in Korean population [18,19]. Depressive symptoms were
classified as normal (K-BDI ,10), mild (K-BDI 10215), and
moderate to severe (K-BDI $16) [19].
Statistical Analysis
Among the baseline characteristics measured, age, anthropo-
metrics, metabolic factors, lifestyle factors, and female reproduc-
tive factors that might be related to either bone density or
depressive symptoms were selected [1,5]. All analyses were
performed for men and women separately because most baseline
characteristics differed by sex. Baseline characteristics according to
depressive symptoms (classified as normal, mild, and moderate to
severe) were compared using analysis of variance for continuous
variables with normal distribution, Kruskal-Wallis test for contin-
uous variables with skewed distribution, and chi-square test for
categorical variables. To investigate whether the mean SI was
significantly different between classified depressive symptoms,
Tukey’s test was performed. Correlations of the SI and covariates
were analyzed using Spearman’s (partial) correlation analyses.
Potential confounders were selected using a stepwise regression
analysis and clinically important variables were retained even if
they did not reach a significant level of association. Selected
covariates were age, BMI, at risk drinking (.2 drinks/day), and
regular exercise ($1/week) in men and age, BMI, at risk drinking
(.1 drink/day), age at menarche, and duration of breastfeeding
(0, 1211, $12 months) in women. A series of unadjusted and
multivariate-adjusted analysis of covariance were performed to
calculate adjusted means and 95% confidence intervals of the SI
according to depressive symptoms. Multivariate-adjusted regres-
sion analysis was performed to yield adjusted R-square to
investigate ability of the covariates to explain the SI. No significant
multicollinearity was confirmed among investigated variables by computing a
variance inflation factor. A p-value less than 5% was considered
significant. All statistical analyses were performed using the SAS
software package (version 9.2.1; SAS Institute, Cary, NC, USA).
Results
In the present study population, mean ages of men and women
were 30.860.6 (ranging 29.1 to 32.2) and 30.760.6 (ranging 29.8
to 32.1) years old, respectively. The percentage of participants with
normal, mild, and moderate to severe depressive symptoms was
69.1% (n= 85), 19.5% (n= 24), and 11.4% (n= 14), respectively,
in men (Table 1) and 54.9% (n= 73), 25.6% (n= 34), and 19.6%
(n= 26), respectively, in women (Table 2). The SI of participants
with moderate to severe depressive symptoms was significantly
lower than that of normal participants in men, but not in women.
Other characteristics of men and women are summarized in
Table 1 and Table 2, respectively.
Table 3 shows the correlations between the SI and covariates.
In men, the SI had a significantly negative correlation with K-BDI
scores in before (r=–0.286, p=0.001) and after (r=–0.228,
p=0.013) adjustment for potential confounders. In addition,
regular exercise was positively correlated to the SI (r=0.190,
p=0.035). In women, participants with a higher SI tended to have
a lower K-BDI score, but the correlation was statistically
insignificant. Rather, the SI was negatively correlated with age
(r=–0.240, p=0.005), at-risk drinking (r=–0.173, p=0.047), age
Depressive Symptoms and Bone Stiffness Index
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of menarche (r=–0.259, p=0.003), and the number of children
(r=–0.195, p=0.025).
Men with depressive symptoms tended to have a lower SI. The
mean SI in men with normal, mild, and moderate to severe
depressive symptoms was 104.563.2, 100.266.0, and 93.267.8,
respectively (p for trend= 0.009), for unadjusted values, and
104.163.1, 100.965.9, and 94.167.8, respectively (p for
trend= 0.021), for multivariate-adjusted values. In contrast,
although the negative trend was observed in an unadjusted model,
the statistical significance was attenuated after adjusting for
potential confounders in women (Table 4). Factors associated
with the SI were demonstrated in Table 5. In men, moderate to
severe depressive symptoms (b=29.993, p=0.021) and regular
exercise (b=6.185, p=0.029) were significantly associated with
the SI. With other covariates, they explained approximately 7% of
the SI. In women, age (b=25.757, p=0.004) and age at
menarche (b=22.532, p=0.001) were significantly associated
with the SI. Together with other covariates, 16% of the variability
of the SI was explained.
Discussion
In the present study examining the association between
depressive symptoms and bone density in apparently healthy
Korean men and women aged 29 to 32 years, K-BDI scores were
negatively correlated to the SI and the participants with more
severe depressive symptoms tended to have a lower SI in men. In
women, similar trends were shown, but were statistically insignif-
icant. Although there is little evidence in young adults, our results
are consistent with a previous study in different ethnic groups: in a
study with 5,171 non-Hispanic white, African-American, and
Mexican-American men and women aged 20 to 39 years
participated in the Third National Health and Nutrition
Examination Survey, major depressive episode or dysthymia
assessed by the Diagnostic Interview Schedule was associated with
lower BMD measured by DXA in men, but not in women [11]. In
this study, gender difference was explained by higher prevalence
rates for depression and dysthymia in women compared to men.
The authors also suggested that impact of depression on physical
activity or diet might be more severe in men than women [11]. For
premenopausal women, however, several studies with relatively
small sample size are available. Although the results were
inconsistent, the majority demonstrated an inverse association
between depression and BMD [7–9,20–23]. In a cross-sectional
study with 25 premenopausal women with MDD (mean age:
30.868.4 years) and 15 normal women (mean age: 31.267.9
years) in Turkey, depressed women had a significantly lower BMD
at the lumbar spine and femur [20]. In a case-control study with
73 premenopausal women aged 30 to 49 years with unipolar
depression and age- and osteoporosis risk factor-matched 47
healthy women in Serbia, women with depression had a
significantly lower BMD at the lumbar spine and femoral neck
Table 1. Baseline characteristics in men aged 29232 years according to depressive symptomsa.
Normal Mild Moderate to severe p-value
(n =85, 69.1%) (n =24, 19.5%) (n=14, 11.4%)
K-BDI score 4 [2,7] 12.5 [10.0, 13.5] 18 [17,21] ,0.001b
Age (years) 30.860.6 30.860.6 30.960.6 0.741c
Weight (Kg) 73.1610.8 75.068.9 71.768.9 0.598c
Height (cm) 173.665.3 174.365.3 173.464.3 0.826c
Body mass index (Kg/m2) 24.363.4 24.763.2 23.862.3 0.670c
Systolic blood pressure (mmHg) 124.0612.1 129.2612.3 123.4610.4 0.152c
Diastolic blood pressure (mmHg) 73.567.8 76.967.3 76.0610.1 0.140c
Laboratory tests
Total cholesterol (mg/dL) 188.2634.2 186.9636.3 194.6636.6 0.788c
HDL cholesterol (mg/dL) 45.469.0 45.769.0 46.469.4 0.928c
Triglycerides (mg/dL) 96 [69, 148] 120 [79, 168] 82.5 [72.0, 140.0] 0.431b
Fasting plasma glucose (mg/dL) 94.469.3 95.567.7 89.668.3 0.127c
HbA1c (%) 5.560.3 5.460.2 5.560.3 0.373c
Insulin (mIU/mL) 7.9 [6.5, 10.7] 7.0 [6.2, 9.6] 7.2 [5.6, 9.0] 0.323b
hsCRP (mg/L) 0.4 [0.2,1.0] 0.9 [0.4, 2.0] 0.6 [0.3, 2.1] 0.086b
Current smoking 44 (51.8) 8 (33.3) 10 (71.4) 0.069d
At-risk drinkinge 36 (42.4) 12 (50.0) 9 (64.3) 0.289d
Regular exercise ($1/week) 32 (37.7) 6 (25.0) 5 (35.7) 0.517d
Bone stiffness index 104.5614.3 100.2612.1 93.2620.8 0.030c
Data are expressed as median [interquartile range], mean 6 standard deviation, or N (%).
K-BDI, the Korean version of the Beck Depression Inventory; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein.
aDepressive symptoms were classified as normal (K-BDI ,10), mild (K-BDI 10215), and moderate to severe (K-BDI $16).
bKruskal-Wallis test for continuous variables with skewed distribution;
cAnalysis of variance for continuous variables with normal distribution;
dChi-square test for categorical variables were performed to compare baseline characteristics according to depressive symptoms (classified as normal, mild, and
moderate to severe).
eAt-risk drinking was defined as consuming an average of more than 2 drinks/day.
doi:10.1371/journal.pone.0069929.t001
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[21]. In another case-control study, BMD at the lumbar spine and
femur of 42 premenopausal women (mean age: 35.467.5 years)
diagnosed with depression were compared to those of age- and
BMI-matched 42 healthy women (mean age: 36.766.7 years) in
Turkey [22]. In this study, no significant association was shown
[22]. In a 36-month prospective study with 92 premenopausal
women between the ages of 21 and 45 years old from the U.S.,
women with MDD tended to have a lower BMD measured by
DXA than the 44 healthy controls [23]. Among Asian populations,
a few studies have been conducted in older adults. In a study with
1,999 Hong Kong Chinese men aged 65 to 92 years, depressed
patients assessed using the Geriatric Depression Scale (n = 169)
had a lower BMD measured by DXA than controls (n = 1,830)
[24]. Another study in 2,611 community-dwelling Chinese aged
55 and older in Singapore demonstrated that depressed patients
assessed using the Geriatric Depression Scale (n = 347) had a
higher risk of having osteoporosis, but the statistical significance
was attenuated after adjusting for covariates [25]. In addition, a
Table 2. Baseline characteristics in women aged 29232 years according to depressive symptomsa.
Normal Mild Moderate to severe p-value
(n =73, 54.9%) (n=34, 25.6%) (n=26, 19.6%)
K-BDI score 5 [3,7] 12.5 [10.0, 14.0] 24 [18,29] ,0.001b
Age (years) 30.760.5 30.860.6 30.860.6 0.692c
Weight (Kg) 56.467.9 57.2611.1 56.3613.2 0.918c
Height (cm) 160.464.9 160.864.2 160.164.4 0.839c
Body mass index (Kg/m2) 21.962.9 22.163.9 21.964.4 0.967c
Systolic blood pressure (mmHg) 108.5612.3 110.0610.2 107.669.5 0.679c
Diastolic blood pressure (mmHg) 65.469.1 68.167.8 66.966.2 0.272c
Laboratory tests
Total cholesterol (mg/dL) 179.1636.1 184.1624.1 174.9627.9 0.540c
HDL cholesterol (mg/dL) 54.8612.7 54.4613.1 52.6613.9 0.752c
Triglycerides (mg/dL) 71 [52, 88] 63.5 [54.0, 84.0] 66.5 [58.0, 98.0] 0.590b
Fasting plasma glucose (mg/dL) 88.169.9 90.9612.3 90.067.2 0.363c
HbA1c (%) 5.460.3 5.560.3 5.560.3 0.411c
Insulin (mIU/mL) 7.6 [6.1, 8.8] 7.6 [6.2, 8.9] 7.9 [6.8, 9.8] 0.367b
hsCRP (mg/L) 0.3 [0.2, 0.7] 0.3 [0.1, 0.8] 0.4 [0.2, 0.8] 0.405b
Current smoking 5 (6.9) 1 (2.9) 7 (26.9) 0.004d
At-risk drinkinge 10 (13.7) 5 (14.7) 7 (26.9) 0.281d
Regular exercise ($1/week) 20 (27.4) 6 (17.7) 5 (19.2) 0.464d
Bone stiffness index 94.8614.4 94.4611.5 88.4614.1 0.115c
Age of menarche 13.261.5 12.861.6 13.361.2 0.338c
Pregnancy (ever) 42 (57.5) 17 (50.0) 17 (65.4) 0.488d
No. of children
None 37 (50.7) 19 (55.9) 11 (42.3) 0.519d
1 2 2 24 (32.9) 8 (23.5) 7 (26.9)
$3 12 (16.4) 7 (20.6) 8 (30.8)
Duration of breastfeeding
None 38 (52.0) 20 (58.8) 12 (46.1) 0.680d
1 2 11 months 21 (28.8) 8 (23.5) 6 (23.1)
$12 months 14 (19.2) 6 (17.7) 8 (30.8)
Oral contraceptives
Never 54 (74.0) 25 (73.5) 16 (61.5) 0.642d
Past users 17 (23.3) 9 (26.5) 9 (34.6)
Current users 2 (2.7) 0 (0.0) 1 (3.9)
Data are expressed as median [interquartile range], mean 6 standard deviation, or N (%).
K-BDI, the Korean version of the Beck Depression Inventory; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein.
aDepressive symptoms were classified as normal (K-BDI ,10), mild (K-BDI 10215), and moderate to severe (K-BDI $16).
bKruskal-Wallis test for continuous variables with skewed distribution;
cAnalysis of variance for continuous variables with normal distribution;
dChi-square test for categorical variables were performed to compare baseline characteristics according to depressive symptoms (classified as normal, mild, and
moderate to severe).
eAt-risk drinking was defined as consuming an average of more than 1 drink/day.
doi:10.1371/journal.pone.0069929.t002
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study with 932 community-dwelling Korean men and women
aged 60 to 80 years had results consistent with the present study;
depressive symptoms measured by the K-BDI showed a signifi-
cantly negative correlation to the SI in older men, but not in
women [26].
Both osteoporosis and depression are a growing health care
burden [2,27], therefore, preventing osteoporosis and depression is
critically important. For young adults continuing to adolescent,
achieving a higher peak bone mass is an important factor to
prevent osteoporosis later in life. Though both genetic and
environmental factors are known to contribute to peak bone mass,
genetic factors such as heredity and sex are not modifiable.
Therefore, preventive approaches should be focused on modifi-
able, environmental factors. Currently, adequate nutritional
intakes (especially calcium intake), exercise, hormonal factors,
Table 3. Correlations of bone stiffness index with covariates
in men and women aged 29232 years.
Men (n=123) Women (n=133)
r p-value r p-value
Age (years) 20.028 0.755 20.240 0.005
Body mass index (Kg/m2) 0.043 0.633 0.120 0.171
Systolic blood pressure (mmHg) 0.004 0.964 0.104 0.232
Diastolic blood pressure (mmHg) 20.054 0.553 20.003 0.975
Laboratory tests
Total cholesterol (mg/dL) 20.145 0.109 0.125 0.152
HDL cholesterol (mg/dL) 20.007 0.935 20.006 0.944
Triglycerides (mg/dL) 20.105 0.247 20.045 0.605
Fasting plasma glucose (mg/dL) 0.083 0.361 20.012 0.889
HbA1c (%) 0.008 0.930 0.060 0.492
Insulin (mIU/mL) 20.028 0.760 0.042 0.631
hsCRP (mg/L) 0.128 0.158 20.014 0.877
Current smoking 0.088 0.333 20.007 0.934
At-risk drinkinga 20.157 0.084 20.173 0.047
Regular exercise ($1/week) 0.190 0.035 0.126 0.148
Age of menarche 20.259 0.003
No. of childrenb 20.195 0.025
Duration of breastfeedingc 20.164 0.060
K-BDI score (unadjusted) 20.286 0.001 20.148 0.089
K-BDI score
(multivariate-adjustedd)
20.228 0.013 20.118 0.184
K-BDI, the Korean version of the Beck Depression Inventory; HDL, high-density
lipoprotein; hsCRP, high-sensitivity C-reactive protein.
aAt-risk drinking was defined as consuming an average of more than 2 drinks/
day for men and 1 drink/day for women.
bThe number of children was classified into 0, 122, and $3.
cDuration of breastfeeding was classified into 0, 1211, and $12 months.
dAdjusted for age, body mass index, at risk drinking (.2 drinks/day), and
regular exercise ($1/week) in men and age, body mass index, at risk drinking
(.1 drink/day), age at menarche, and duration of breastfeeding (0, 1211, and
$12 months) in women.
doi:10.1371/journal.pone.0069929.t003
Table 4. Bone stiffness index in men and women aged 29232 years according to severity of depressive symptoms.
Men (n=123) Women (n=133)
N Unadjusted SI
Multivariate-adjusted
SIa N Unadjusted SI
Multivariate-adjusted
SIb
Depressive symptomsc
Normal 85 104.563.2 104.163.1 73 94.863.2 94.662.9
Mild 24 100.266.0 100.965.9 34 94.464.6 93.564.3
Moderate to severe 14 93.267.8 94.167.8 26 88.465.3 90.165.0
p for trend 0.009 0.021 0.043 0.128
SI, bone stiffness index; K-BDI, the Korean version of the Beck Depression Inventory.
aAdjusted for age, body mass index, at risk drinking (.2 drinks/day), and regular exercise ($1/week).
bAdjusted for age, body mass index, at risk drinking (.1 drink/day), age at menarche, and duration of breastfeeding (0, 1211, and $12 months).
cDepressive symptoms were classified as normal (K-BDI ,10), mild (K-BDI 10215), and moderate to severe (K-BDI $16).
doi:10.1371/journal.pone.0069929.t004
Table 5. Factors associated with bone stiffness index in men
and women aged 29232 years.
Men (n=123) Women (n=133)
PE SE p-value PE SE
p-
value
Depressive symptomsa
Normal 2 2
Mild 23.224 3.386 0.343 20.492 2.654 0.853
Moderate to severe 29.993 4.252 0.021 24.671 2.916 0.112
Age 21.780 2.284 0.437 25.757 1.937 0.004
Body mass index 0.028 0.412 0.946 0.253 0.316 0.426
At-risk drinkingb 24.101 2.684 0.129 26.494 2.975 0.031
Regular exercise
($1/week)
6.185 2.804 0.029 3.932 2.604 0.134
Age at menarche 22.532 0.753 0.001
Duration of
breastfeeding
None 2
1211 months 20.704 2.632 0.790
$12 months 24.535 2.907 0.121
Adjusted R-square 0.071 0.160
PE, parameter estimate; SE, standard error.
K-BDI, the Korean version of the Beck Depression Inventory.
aDepressive symptoms were classified as normal (K-BDI ,10), mild (K-BDI
10215), and moderate to severe (K-BDI $16).
bAt-risk drinking was defined as consuming an average of more than 2 drinks/
day for men and 1 drink/day for women.
doi:10.1371/journal.pone.0069929.t005
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and exposure to behavioral risk factors are known determinants of
peak bone mass [3,28]. In addition to them, if depressive
symptoms negatively affect bone mass in young adults, prevention
or treatment of depression in young adults might be crucial.
Despite the growing evidence of the link between depression
and osteoporosis, the biologic mechanism remains unclear.
Evidence to support that depression may be a risk factor for
osteoporosis includes alteration in the adrenergic axis and the
hypothalamic-pituitary-adrenal axis [7,29]. Experimentally de-
pressed mice displayed impaired bone formation and an increase
in bone norephinephrine levels [30]. In these mice, the fact that b-
adrenergic antagonist blocked bone loss suggested that the
sympathetic nervous system mediate the depression-triggered
bone loss [30]. Glucocorticoids, which are known to correlate to
depression [31], also suppress bone formation and increase bone
resorption via inhibiting osteoblastogenesis and promoting apop-
tosis of osteoblasts and osteocytes [32]. Another possible bone-
brain connection is related to serotonin [33] of which the target
tissues include the brain and bone [34]. Although the effect of
serotonin on bone differs depending on its origin, serotonin
activity in the brain favorably influences bone mass and precedes
duodenum-derived serotonins that inhibit bone formation [35]. As
serotonins can be stored in or released by platelet during the
clotting process, a reduced uptake of serotonin in platelets and
neurons during depression possibly influences free serotonin on
bone mass [33]. In practice, depressed patients treated with
selective serotonin reuptake inhibitor displayed decreased BMD
[36]. Another possible mechanism is that depression and low
BMD may share common risk factors or common pathways. Poor
health behavior such as smoking, increased alcohol consumption,
low physical activity, or comorbidity was associated with both
depression and BMD [8]. Also low diet quality [37,38] or changes
in sleeping patterns [39] in depressed patients may also affect
BMD via inadequate nutrition [40,41], impaired insulin sensitivity
[42], or alteration of neurotransmitter receptor systems such as
serotonin, norephinephrine or glucocorticoids [43,44]. Pro-
inflammatory markers (e.g., interleukin-6 or C-reactive protein)
were elevated in depressed patients [45,46] and were also
associated with low BMD [46,47]. In addition, sex hormones
including estrogen and testosterone were related to both depres-
sion [48,49] and bone formation and turnover [50]. We therefore
controlled for current smoking, at-risk drinking, and regular
exercise as covariates in the multivariate-adjusted analyses. With
regards to comorbidity, our participants were young and relatively
healthy with no reported cancer, stroke, or ischemic heart disease.
Further, we confirmed that BMI, blood pressure, serum levels of
C-reactive protein, cholesterol, and glucose were not significantly
different among participants across the severity of depressive
symptoms in this study population (Table 1).
In this study, sex difference existed in the results: the negative
association between depressive symptoms and the SI was observed
in men, but not in women. According to a study from a nationwide
survey in Korea, BMD significantly decreased from the third
decade of life in men. Meanwhile, in women, BMD plateaued
until the fifth decade and rapidly declined peri- and post-
menopause [51]. Therefore, early bone loss occurs more
frequently in men because male bone may be more vulnerable
to factors such as depressive symptoms than female bone.
Additionally, sex hormones, especially estrogen in women, are
one of the most important determinants of bone health [3]. In fact,
age at menarche was negatively associated with the SI in women
(Table 2). It can be explained that women with earlier menarche
might be exposed to more estrogen, therefore, strong protective
effects of female sex hormones might overcome the negative effects
of psychological stress on bone density.
This study has several limitations. First, the sample size of the
present study was relatively small. However, considering that age
is one of the most determining factors for bone density, the fact
that study was performed in a focused age group, between ages of
29 and 32 years, could be an added strength. In addition, this
study investigated the association between depressive symptoms
and bone density in both Korean men and women; therefore, our
study might provide evidence for young Asian populations.
Second, the K-BDI is a well-known screening tool to detect
depression in normal populations, so K-BDI scores might provide
the information of having depressive symptoms in this study
population. However, the K-BDI is not a diagnostic tool for
depression; therefore, the study results cannot be generalized to
patients with clinically diagnosed depression. Third, we measured
the SI using a quantitative ultrasound device. Although the SI at
the os calcis correlates with BMD by DXA which is the current
gold standard method [14,52], further confirmation with DXA is
needed. Fourth, diet and sleeping patterns, which may be different
in depressed participants, were not evaluated in this study. Since
insufficient nutrition and a low sleep quality may affect BMD,
residual confounding possibly exists. Fifth, the mean age of
participants was 31 years. Thereby, their bone masses may be
close to their peaks. However, we did not serially measure their SI,
so the effect of depressive symptoms or other covariates on peak
bone mass could not be evaluated in this study. Finally, due to the
cross-sectional design and limited information on biological
mechanisms, we cannot conclude a causal relationship between
depressive symptoms and the SI.
In conclusion, the present study demonstrated a negative
association between depressive symptoms and the SI in apparently
health young Korean men, but not in women. Further studies are
necessary to evaluate the effect of depressive symptoms on lower
bone density in young adulthood and the impact of depression on
developing osteoporosis or osteoporotic fractures later in life.
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